Palbociclib and ponatinib induce regression of acute myeloid leukemia in patient-derived xenograft model.
Authors | |
---|---|
Year of publication | 2021 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |
Authors | |
---|---|
Year of publication | 2021 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |